<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2125</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina General Integral]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Med Gen Integr]]></abbrev-journal-title>
<issn>0864-2125</issn>
<publisher>
<publisher-name><![CDATA[ECIMED]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21251995000200018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Mediadores inflamatorios y asma bronquial]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarez Sintes]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarez Sintes]]></surname>
<given-names><![CDATA[Rogelio]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fernández Maceiro]]></surname>
<given-names><![CDATA[Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Peraza Fernández]]></surname>
<given-names><![CDATA[José Luis]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Policlínico Docente Antonio Maceo  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Hospital Clinicoquirúrgico Docente General Calixto García  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Clínica Nacional de Asma Bronquial  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A04">
<institution><![CDATA[,Sociedad Cubana de Medicina Familiar  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>1995</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>1995</year>
</pub-date>
<volume>11</volume>
<numero>2</numero>
<fpage>176</fpage>
<lpage>179</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21251995000200018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21251995000200018&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21251995000200018&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[ <DIV ALIGN=right>   <H5>   <A HREF="mgisu295.htm">    </A><A HREF="mgi13295.htm">    <BR>     </A></H5> </DIV>      <H3> Actualidad</H3>      <H2>   Mediadores inflamatorios y asma bronquial*</H2>   <I>Roberto Alvarez Sintes,<SUP>1</SUP> Rogelio Alvarez Sintes,<SUP>2</SUP>   Enrique Fern&aacute;ndez Maceiro<SUP>3</SUP> y Jos&eacute; Luis Peraza   Fern&aacute;ndez<SUP>4</SUP></I>       <BLOCKQUOTE>* Conferencia impartida en el Curso Nacional "Actualizaci&oacute;n   en Asma Bronquial" desarrollado en el Ministerio de Salud P&uacute;blica   de Cuba del 16 al 20 de mayo de 1994.</BLOCKQUOTE>      <OL>       <LI>   Especialista de I Grado en Medicina General Integral. Miembro de la Junta   Directiva de la Sociedad Cubana de Medicina Familiar. Policl&iacute;nico   Docente "Antonio Maceo".</LI>          <LI>   Especialista de I Grado en Medicina Interna y en Cuidados Intensivos. Entrenado   en Farmacolog&iacute;a Cl&iacute;nica. Miembro de la Comisi&oacute;n Nacional   de Asma Bronquial del MINSAP de Cuba. Hospital Clinicoquir&uacute;rgico   Docente "General Calixto Garc&iacute;a".</LI>          <LI>   Especialita de I Grado en Medicina Interna. Presidente de la Comisi&oacute;n   Nacional de Asma Bronquial del MINSAP de Cuba. Director de la Cl&iacute;nica   Nacional de Asma Bronquial.</LI>          <LI>   Especialista de I Grado en Medicina General Integral. Presidente de la   Filial Provincial en Ciudad de La Habana de la Sociedad Cubana de Medicina   Familiar.</LI>       </OL>      <H4>   INTRODUCCION</H4>   El asma, enfermedad inflamatoria pulmonar, se caracteriza por una obstrucci&oacute;n   al flujo a&eacute;reo variable y reversible.          <P>Pueden considerarse hallazgos t&iacute;picos de ella los siguientes:   <OL>       <LI>   Estrechamiento excesivo de las v&iacute;as respiratorias en respuesta a   una variedad de est&iacute;mulos no relacionados.</LI>          ]]></body>
<body><![CDATA[<LI>   Hiperreactividad bronquial.</LI>          <LI>   Hipersecreci&oacute;n de las gl&aacute;ndulas submucosas.</LI>          <LI>   Marcada quimiotaxis y por tanto, marcado infiltrado inflamatorio.</LI>          <LI>   Da&ntilde;o microvascular y epitelial.</LI>       </OL>   Hoy se sabe, que estos cambios patol&oacute;gicos se deben al efecto que   provocan m&uacute;ltiples mediadores sobre los receptores que existen a   nivel de las c&eacute;lulas diana.1-4       <CENTER>   <H4>   MEDIADORES RESPONSABLES DE BRONCOCONSTRICCION</H4></CENTER>          <CENTER><TABLE BORDER=0 CELLPADDING=4 >   <TR>   <TD VALIGN=TOP WIDTH="50%">Efecto pronunciado&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Prostaglandinas D2 y F2 pronunciado Alfa</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Tromboxanos</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Leucotrienos C4, D4 y E4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Factor activador de plaquetas</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Neuroquinina A</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">Efecto moderado&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Histamina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Bradiquinina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Adenosina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Sustancia P</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Complemento</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Radicales de ox&iacute;geno</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">Efecto incierto&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Serotonina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">Informaci&oacute;n no disponible</TD>      <TD VALIGN=TOP WIDTH="50%">Prostaglandina E2</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="50%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="50%">Leucotrieno B4</TD>   </TR>   </TABLE></CENTER>          <CENTER>   <H4>   MEDIADORES RESPONSABLES DE HIPERREACTIVIDAD BRONQUIAL</H4></CENTER>          <CENTER><TABLE BORDER=0 CELLPADDING=4 >   <TR>   <TD VALIGN=TOP WIDTH="45%">Efecto pronunciado&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Factor activador plaquetario</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">Efecto moderado&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Prostaglandina D2 y F2 moderado Alfa</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Tromboxanos</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Leucotrieno B4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">Efecto incierto&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Leucotrienos C4 D4 y E4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">Informaci&oacute;n no disponible&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Histamina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Prostaglandina E2</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Bradiquinina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Adenosina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Sustancia P</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Neuroquinina A</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">Complemento</TD>      <TD VALIGN=TOP WIDTH="55%">&nbsp;</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Serotonina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="45%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="55%">Radicales de ox&iacute;geno</TD>   </TR>   </TABLE></CENTER>   &nbsp;       <CENTER>   <H4>   MEDIADORES RESPONSABLES DE LA HIPERSECRECION RESPIRATORIA</H4></CENTER>          ]]></body>
<body><![CDATA[<CENTER><TABLE BORDER=0 CELLPADDING=4 >   <TR>   <TD VALIGN=TOP WIDTH="40%">Efecto pronunciado</TD>      <TD VALIGN=TOP WIDTH="60%">Leucotrienos C4, D4, y R4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Sustancia P</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">Efecto moderado</TD>      <TD VALIGN=TOP WIDTH="60%">Histamina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Prostaglandina D2, F2 Alfa y E2</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">Factor activador de plaquetas</TD>      <TD VALIGN=TOP WIDTH="60%">&nbsp;</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Bradiquinina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Neuroquinina A</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Complemento</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">Informaci&oacute;n no disponible&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Tromboxano</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Adenosina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="40%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="60%">Serotonina</TD>   </TR>   </TABLE></CENTER>   &nbsp;       <CENTER>   <H4>   MEDIADORES RESPONSABLES DE QUIMIOTAXIS Y POR TANTO DETERMINANTES DEL INFILTRADO   INFLAMATORIO</H4></CENTER>          <CENTER><TABLE BORDER=0 CELLPADDING=4 >   <TR>   <TD VALIGN=TOP WIDTH="56%">Efecto pronunciado</TD>      <TD VALIGN=TOP WIDTH="44%">Leucotrieno B4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Factor activador de plaquetas</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Complemento</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">Efecto moderado&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Histamina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Prostaglandina E2</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">Efecto incierto&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Tromboxano</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Sustancia P</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">Informaci&oacute;n no disponible</TD>      <TD VALIGN=TOP WIDTH="44%">Prostaglandina D2 y F2&nbsp;</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Alfa</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Leucotrienos C4, D4 y E4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Adenosina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="56%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="44%">Radicales de ox&iacute;geno</TD>   </TR>   </TABLE></CENTER>   &nbsp;       <CENTER>   <H4>   MEDIADORES RESPONSABLES DEL DA&Ntilde;O MICROVASCULAR Y EPITELIAL</H4></CENTER>          <CENTER><TABLE BORDER=0 CELLPADDING=4 >   <TR>   <TD VALIGN=TOP WIDTH="38%">Efecto pronunciado</TD>      <TD VALIGN=TOP WIDTH="63%">Leucotrienos C4, D4, E4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Factor activador plaquetario</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Bradiquinina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Sustancia P</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">Efecto moderado&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Histamina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Neuroquinina A</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Serotonina</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Complemento</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Radicales de ox&iacute;geno</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">Efecto incierto&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Leucotrieno B4</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">Informaci&oacute;n no disponible&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Prostaglandina D2 y F2 Alfa</TD>   </TR>      <TR>   <TD VALIGN=TOP WIDTH="38%">&nbsp;</TD>      <TD VALIGN=TOP WIDTH="63%">Adenosina</TD>   </TR>   </TABLE></CENTER>   &nbsp;   <H4>   REFERENCIAS BIBLIOGRAFICAS</H4>      <OL>       <LI>   Pratter MR, Irwin RS. Insuficiencia respiratoria: asma bronquial. En: Rippe   JM, Manual de cuidados intensivos. 2 ed. Barcelona: Salvat, 1991:224-34.   (series manuales espiral).</LI>          <LI>   Barnes JP, Fan-Chung K, Page P. Inflamatory mediators and asthma. Pharmacol   Rev 1990;49(1):49-73.</LI>          <LI>   Phillip Dellinger R. Life-thereatening bronchospasm in the asthmatic. En:   Civetta JM, Taylor RW, Kirby RR. Critical care. 2 ed. Philadelphia: Lippincott,   1992:432-5.</LI>          <!-- ref --><LI>   Schroeder SA. Bronchial asthma reviews. Mt Sinai J Med 1992;59(7):27-40.</LI>    </OL>             ]]></body>
<body><![CDATA[<P>Recibido: 8 de junio de 1994. Aprobado: 13 de septiembre de 1994.          <P>Dr. <I>Roberto Alvarez Sintes. </I>Calle 100 No. 5501 esquina a 55,   Marianao 14, Ciudad de La Habana,Cuba.       <DIV ALIGN=right>   <H5>   <FONT SIZE=-1><A HREF="mgisu295.htm">    </A><A HREF="mgi13295.htm"></A></FONT></H5></DIV>           ]]></body><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pratter]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Irwin]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Insuficiencia respiratoria: asma bronquial]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rippe]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<source><![CDATA[Manual de cuidados intensivos]]></source>
<year>1991</year>
<page-range>224-34</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[Fan-Chung]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Page]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Inflamatory mediators and asthma]]></article-title>
<source><![CDATA[Pharmacol Rev]]></source>
<year>1990</year>
<volume>49</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-73</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phillip Dellinger]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Life-thereatening bronchospasm in the asthmatic]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Civetta]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Kirby]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
</person-group>
<source><![CDATA[Critical care]]></source>
<year>1992</year>
<page-range>432-5</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Bronchial asthma reviews]]></article-title>
<source><![CDATA[Mt Sinai J Med]]></source>
<year>1992</year>
<volume>59</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>27-40</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
